IE 11 is not supported. For an optimal experience visit our site on another browser.

Could full FDA approval of Pfizer Covid vaccine boost nationwide vaccination rate?

03:18

Professor and physician at Georgetown University and former Chief Scientist at the FDA, Dr. Jesse Goodman, explains the difference between emergency use authorization and full approval of Pfizer’s Covid-19 vaccine and whether full authorization could impact vaccine rates across the country.